The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy
Published version of a preprint
Abstract
Background: Neurodegeneration, an early event in the pathogenesis of diabetic retinopathy (DR), precedes clinically detectable microvascular damage. Autophagy dysregulation is considered a potential cause of neuronal cell loss, however underlying mechanisms remain unclear. The mechanistic target of rapamycin (mTOR) integrates diverse environmental signals to coordinate biological processes, including autophagy. Here, we investigated the role of mTOR signaling in neuronal cell death in DR. Methods: Diabetes was induced by a single intraperitoneal injection of streptozotocin and tissue samples were harvested at 1, 2, 3, 4, and 6 months of diabetes. Early-stage of DR was investigated in 1-month-diabetic mice treated with phlorizin (two daily subcutaneous injections at a dose of 200 mg/kg of body weight during the last 7 full days of the experiment and the morning of the 8th day, 3 h before sacrifice) or rapamycin (daily intraperitoneal injections, at a dose of 3 mg/kg for the same period as for phlorizin treatment). The effect of autophagy modulation on retinal ganglion cells was investigated in 3-months-diabetic mice treated with phlorizin (two daily subcutaneous injections during the last 10 full days of the experiment and the morning of the 11th day, 3 h before sacrifice) or MHY1485 (daily i.p. injections, at a dose of 10 mg/kg for the same period as for phlorizin treatment). Tissue samples obtained from treated/untreated diabetic mice and age-matched controls were used for Western blot and histologic analysis. Results: mTOR-related proteins and glucose transporter 1 (GLUT1) was upregulated at 1 month and downregulated in the following period up to 6 months. Diabetes-induced neurodegeneration was characterized by an increase of apoptotic marker—cleaved caspase 3, a decrease of the total number of cells, and NeuN immunoreactivity in the ganglion cell layer, as well as an increase of autophagic protein. Insulin-independent glycemic control restored the mTOR pathway activity and GLUT1 expression, along with a decrease of autophagic and apoptotic proteins in 3-months-diabetic mice neuroretina. However, blockade of autophagy using MHY1485 resulted in a more protective effect on ganglion cells compared with phlorizin treatment. Conclusion: Collectively, our study describes the mechanisms of neurodegeneration through the hyperglycemia/ mTOR/ autophagy/ apoptosis pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in RGCs, we and others have demonstrated that mTOR inactivation not only regulated autophagy, but also induced neurite shortening during RGC injury, while additional mTOR stimulation can trigger RGC dendrite and axon regeneration [49, 50, 58, 60, 93, 94]”
In the citing paper
“Likewise, recent evidence has demonstrated that dysfunction of the autophagy degradation pathway may be involved in RGC-associated neurodegenerative diseases, including glaucoma, optic atrophy, and diabetic retinopathy [24, 60, 69].”
In the citing paper
“As RGC survival relies upon the homeostatic balance between mTOR and autophagy signaling [60]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Flaxman, S. R., Bourne, R. R. A., Resnikoff, S., Ackland, P., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., Keeffe, J., Kempen, J. H., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30393-5 · Cited by 3,477
Self-citationRole of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks
Alers, S., Löffler, A. S., Wesselborg, S., & Stork, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06159-11 · Cited by 1,483
Rapamycin: one drug, many effects
Li, J., Kim, S. G., & Blenis, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.001 · Cited by 1,287
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
Glucose transporters in the 21st Century
Thorens, B., & Mueckler, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00712.2009 · Cited by 1,013
mTOR coordinates protein synthesis, mitochondrial activity and proliferation
Morita, M., Gravel, S.-P., Hulea, L., Larsson, O., Pollak, M., St-Pierre, J., & Topisirovic, I. (2015) · Cell Cycle · doi:10.4161/15384101.2014.991572 · Cited by 552
Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess
Wellen, K. E., & Thompson, C. B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.004 · Cited by 486
Research works printed but not linked: 72
- Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36. https://doi.org/10.1016/S0140-6736(09)62124-3. · DOI · Paper page
- Gadkari SS, Maskati QB, Nayak BK. Prevalence of diabetic retinopathy in India: The All India Ophthalmological Society Diabetic Retinopathy Eye Screening Study 2014. Indian J Ophthalmol. 2016;64(1):38–44. https://doi.org/10.4103/0301-4738.178144. · DOI · Paper page
- Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol. 2015;99(1):64–8. https://doi.org/10.1136/bjophthalmol-2013-304017. · DOI · Paper page
- Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–77. https://doi.org/10.1111/ceo.12696. · DOI · Paper page
- Bandello F, Lattanzio R, Zucchiatti I, Del Turco C. Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol. 2013;50(1):1–20. https://doi.org/10.1007/s00592-012-0449-3. · DOI
- Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013;4(6):290. https://doi.org/10.4239/wjd.v4.i6.290. · DOI · Paper page
- Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156–86. https://doi.org/10.1016/j.preteyeres.2015.08.001. · DOI · Paper page
- Cole ED, Novais EA, Louzada RN, Waheed NK. Contemporary retinal imaging techniques in diabetic retinopathy: a review. Clin Exp Ophthalmol. 2016;44(4):289–99. https://doi.org/10.1111/ceo.12711. · DOI · Paper page
- Tavares Ferreira J, Alves M, Dias-Santos A, et al. Retinal neurodegeneration in diabetic patients without diabetic retinopathy. Investig Ophthalmol Vis Sci. 2016;57(14):6455–60. https://doi.org/10.1167/iovs.16-20215. · DOI
- Jackson GR, Barber AJ. Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep. 2010;10(5):380–4. https://doi.org/10.1007/s11892-010-0132-4. · DOI
- Han Y, Adams AJ, Bearse MA, Schneck ME. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol. 2004;122(12):1809–15. https://doi.org/10.1001/archopht.122.12.1809. · DOI
- Harrison WW, Bearse MA, Ng JS, et al. Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Investig Ophthalmol Vis Sci. 2011;52(2):772–7. https://doi.org/10.1167/iovs.10-5931. · DOI · Paper page
- Lecleire-Collet A, Audo I, Aout M, et al. Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Investig Ophthalmol Vis Sci. 2011;52(6):2861–7. https://doi.org/10.1167/iovs.10-5960. · doi:10.1167/iovs.10-5960
- Verma A, Raman R, Vaitheeswaran K, et al. Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy? Ophthalmic Res. 2012;47(4):202–7. https://doi.org/10.1159/000333220. · DOI
- Vujosevic S, Midena E. Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and müller cells alterations. J Diabetes Res. 2013;2013:905058. https://doi.org/10.1155/2013/905058. · DOI · Paper page
- Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest. 1998;102(4):783–91. https://doi.org/10.1172/JCI2425. · DOI · Paper page
- Carrasco E, Hernandez C, Miralles A, et al. Lower somatostatin expression is an early event in diabetic retinopathy and is. Diabetes Care. 2007;30(11):2902–8. https://doi.org/10.2337/dc07-0332.Additional. · doi:10.2337/dc07-0332.additional
- Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. Investig Ophthalmol Vis Sci. 2007;48(11):5152–9. https://doi.org/10.1167/iovs.07-0427. · DOI
- Aung MH, Park H, Han MK, et al. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci. 2014;34(3):726–36. https://doi.org/10.1523/JNEUROSCI.3483-13.2014. · DOI
- Gastinger MJ, Singh RSJ, Barber AJ. Loss of Cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Investig Opthalmology Vis Sci. 2006;47(7):3143. https://doi.org/10.1167/iovs.05-1376. · DOI · Paper page
- Rungger-Brändle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Investig Ophthalmol Vis Sci. 2000;41(7):1971–80.
- Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci. 2000;17(3):463–71. https://doi.org/10.1017/S0952523800173122. · DOI · Paper page
- Sasaki M, Ozawa Y, Kurihara T, et al. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia. 2010;53(5):971–9. https://doi.org/10.1007/s00125-009-1655-6. · DOI · Paper page
- Abcouwer SF, Gardner TW. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci. 2014;1311:174–90. https://doi.org/10.1111/nyas.12412. · DOI · Paper page
- Simó R, Hernández C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res. 2015;48:160–80. https://doi.org/10.1016/j.preteyeres.2015.04.003. · DOI · Paper page
- Simó R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61(9):1902–12. https://doi.org/10.1007/s00125-018-4692-1. · DOI · Paper page
- Gardner TW, Davila JR. The neurovascular unit and the pathophysiologic basis of diabetic retinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2017;255(1):1–6. https://doi.org/10.1007/s00417-016-3548-y. · DOI · Paper page
- Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease. Diabetes. 2006;55(9):2401–11. https://doi.org/10.2337/db05-1635. · DOI · Paper page
- Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Investig Ophthalmol Vis Sci. 2011;52(2):1156–63. https://doi.org/10.1167/iovs.10-6293. · DOI · Paper page
- Simó R, Hernández C. Neurodegeneration is an early event in diabetic retinopathy: Therapeutic implications. Br J Ophthalmol. 2012;96(10):1285–90. https://doi.org/10.1136/bjophthalmol-2012-302005. · DOI
- Piano I, Novelli E, Della Santina L, Strettoi E, Cervetto L, Gargini C. Involvement of autophagic pathway in the progression of retinal degeneration in a mouse model of diabetes. Front Cell Neurosci. 2016;10(FEB):42. https://doi.org/10.3389/fncel.2016.00042. · DOI
- Park H-YL, Kim JH, Park CK. Different contributions of autophagy to retinal ganglion cell death in the diabetic and glaucomatous retinas. Sci Rep. 2018;8(1):13321. https://doi.org/10.1038/s41598-018-30165-7. · DOI
- De Faria JMLJBL, Duarte DA, Montemurro C, et al. Defective autophagy in diabetic retinopathy. Investig Ophthalmol Vis Sci. 2016;57(10):4356–66. https://doi.org/10.1167/iovs.16-19197. · DOI
- Lin WJ, Kuang HY. Oxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells. Autophagy. 2014;10(10):1692–701. https://doi.org/10.4161/auto.36076. · DOI
- Di RM, Distefano G, Gagliano C, Rusciano D, Malaguarnera L. Autophagy in diabetic retinopathy. Curr Neuropharmacol. 2016;14(8):810–25. https://doi.org/10.2174/1570159X14666160321122900. · DOI
- Saha S, Panigrahi DP, Patil S, Bhutia SK. Autophagy in health and disease: a comprehensive review. Biomed Pharmacother. 2018;104:485–95. https://doi.org/10.1016/j.biopha.2018.05.007. · DOI · Paper page
- Ehrenkranz JRL, Lewis NG, Kahn CR, Roth J. Phlorizin: a review. Diabetes Metab Res Rev. 2005;21(1):31–8. https://doi.org/10.1002/dmrr.532. · DOI · Paper page
- Fort PE, Losiewicz MK, Reiter CEN, et al. Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance. PLoS ONE. 2011. https://doi.org/10.1371/journal.pone.0026498. · DOI
- Sällström J, Eriksson T, Fredholm BB, Persson AEG, Palm F. Inhibition of sodium-linked glucose reabsorption normalizes diabetes-induced glomerular hyperfiltration in conscious adenosine A1-receptor deficient mice. Acta Physiol. 2014;210(2):440–5. https://doi.org/10.1111/apha.12152. · DOI
- Yang JY, Madrakhimov SB, Ahn DH, et al. mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV. Cell Commun Signal. 2019;17(1):64. https://doi.org/10.1186/s12964-019-0380-0. · DOI
- Zhou J, Yao W, Li C, Wu W, Li Q, Liu H. Administration of follicle-stimulating hormone induces autophagy via upregulation of HIF-1α in mouse granulosa cells. Cell Death Dis. 2017;8(8):e3001. https://doi.org/10.1038/cddis.2017.371. · DOI
- Jampol LM, Glassman AR, Sun J. Evaluation and care of patients with diabetic retinopathy. N Engl J Med. 2020;382(17):1629–37. https://doi.org/10.1056/NEJMra1909637. · DOI · Paper page
- Kumagai AK. Glucose transport in brain and retina: Implications in the management and complications of diabetes. Diabetes Metab Res Rev. 1999;15(4):261–73. https://doi.org/10.1002/(SICI)1520-7560(199907/08)15:4%3c261::AID-DMRR43%3e3.0.CO;2-Z. · DOI · Paper page
- Kumagai AK, Glasgow BJ, Pardridge WM. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Investig Ophthalmol Vis Sci. 1994;35(6):2887–94.
- Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H. Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in cells of the blood-retinal barrier in the rat. Investig Ophthalmol Vis Sci. 1992;33(2):377–83.
- Gospe SM, Baker SA, Arshavsky VY. Facilitative glucose transporter Glut1 is actively excluded from rod outer segments. J Cell Sci. 2010;123(Pt 21):3639–44. https://doi.org/10.1242/jcs.072389. · DOI
- Mantych GJ, Hageman GS, Devaskar SU. Characterization of glucose transporter isoforms in the adult and developing human eye. Endocrinology. 1993;133(2):600–7. https://doi.org/10.1210/endo.133.2.8344201. · doi:10.1210/endo.133.2.8344201
- Calado SM, Alves LS, Simão S, Silva GA. GLUT1 activity contributes to the impairment of PEDF secretion by the RPE. Mol Vis. 2016;22:761–70.
- Cloherty EK, Diamond DL, Heard KS, Carruthers A. Regulation of GLUT1-mediated sugar transport by an antiport/uniport switch mechanism. Biochemistry. 1996;35(40):13231–9. https://doi.org/10.1021/bi961208t. · doi:10.1021/bi961208t
- Adachi-Uehara N, Kato M, Nimura Y, et al. Up-regulation of genes for oxidative phosphorylation and protein turnover in diabetic mouse retina. Exp Eye Res. 2006;83(4):849–57. https://doi.org/10.1016/j.exer.2006.04.012. · DOI
- Nyengaard JR, Ido Y, Kilo C, Williamson JR. Interactions between diabetes and hypoxia retinopathy 2004 implications for diabetic retinopathy. Diabetes. 2004;53:2931–8. · DOI
- Imai H, Singh RSJ, Fort PE, Gardner TW. Neuroprotection for diabetic retinopathy. Dev Ophthalmol. 2009;44:56–68. https://doi.org/10.1159/000223946. · DOI
- Fernandes R, Suzuki K, Kumagai AK. Inner blood-retinal barrier GLUT1 in long-term diabetic rats: an immunogold electron microscopic study. Investig Ophthalmol Vis Sci. 2003;44(7):3150–4. https://doi.org/10.1167/iovs.02-1284. · DOI
- Fernandes R, Carvalho AL, Kumagai A, et al. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation. Mol Vis. 2004;10:618–28.
- Badr GA, Tang J, Ismail-Beigi F, Kern TS. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes. 2000;49(6):1016–21. https://doi.org/10.2337/diabetes.49.6.1016. · DOI
- Kumagai AK, Vinores SA, Pardridge WM. Pathological upregulation of inner blood-retinal barrier Glut1 glucose transporter expression in diabetes mellitus. Brain Res. 1996;706(2):313–7. https://doi.org/10.1016/0006-8993(95)01335-0. · DOI
- Tang J, Mohr S, Du YP, Kern TS. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr Eye Res. 2003;27(1):7–13. https://doi.org/10.1076/ceyr.27.2.7.15455. · doi:10.1076/ceyr.27.2.7.15455
- Roy A, Hashmi S, Li Z, Dement AD, Cho KH, Kim JH. The glucose metabolite methylglyoxal inhibits expression of the glucose transporter genes by inactivating the cell surface glucose sensors Rgt2 and Snf3 in yeast. Mol Biol Cell. 2016;27(5):862–71. https://doi.org/10.1091/mbc.E15-11-0789. · doi:10.1091/mbc.e15-11-0789
- Stenina O. Regulation of vascular genes by glucose. Curr Pharm Des. 2005;11(18):2367–81. https://doi.org/10.2174/1381612054367283. · doi:10.2174/1381612054367283
- Stitt AW. AGEs and diabetic retinopathy. Investig Ophthalmol Vis Sci. 2010;51(10):4867–74. https://doi.org/10.1167/iovs.10-5881. · DOI · Paper page
- Kim D-I, Lim S-K, Park M-J, Han H-J, Kim G-Y, Park SH. The involvement of phosphatidylinositol 3-kinase /Akt signaling in high glucose-induced downregulation of GLUT-1 expression in ARPE cells. Life Sci. 2007;80(7):626–32. https://doi.org/10.1016/J.LFS.2006.10.026. · DOI
- Dehdashtian E, Mehrzadi S, Yousefi B, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018;193:20–33. https://doi.org/10.1016/j.lfs.2017.12.001. · DOI · Paper page
- Saxton RA, Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017;168(6):960–76. https://doi.org/10.1016/j.cell.2017.02.004. · DOI · Paper page
- Harwood FC, Klein Geltink RI, O’Hara BP, et al. ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer. Sci Adv. 2018. https://doi.org/10.1126/sciadv.aar3938. · DOI
- Buller CL, Heilig CW, Brosius FC. GLUT1 enhances mTOR activity independently of TSC2 and AMPK. Am J Physiol Ren Physiol. 2011;301(3):F588–96. https://doi.org/10.1152/ajprenal.00472.2010. · DOI
- Lu L, Seidel CP, Iwase T, et al. Suppression of GLUT1; A new strategy to prevent diabetic complications. J Cell Physiol. 2013;228(2):251–7. https://doi.org/10.1002/jcp.24133. · DOI
- Wei J, Jiang H, Gao H, Wang G. Blocking Mammalian target of rapamycin (mTOR) attenuates HIF-1α pathways engaged-vascular endothelial growth factor (VEGF) in diabetic retinopathy. Cell Physiol Biochem. 2016;40(6):1570–7. https://doi.org/10.1159/000453207. · DOI
- Zhang MH, Jiang JZ, Cai YL, Piao LH, Jin Z. Significance of dynamic changes in gastric smooth muscle cell apoptosis, PI3K-AKT-mTOR and AMPK-mTOR signaling in a rat model of diabetic gastroparesis. Mol Med Rep. 2017;16(2):1530–6. https://doi.org/10.3892/mmr.2017.6764. · DOI
- Shen L, You B, Gao H, Li B, Yu F, Pei F. Effects of phlorizin on vascular complications in diabetes db/db mice. Chin Med J Engl. 2012;125(20):3692–6. https://doi.org/10.3760/cma.j.issn.0366-6999.2012.20.017. · doi:10.3760/cma.j.issn.0366-6999.2012.20.017
- Zhang S, Li B, Li X, et al. Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db/db mice. Mol Vis. 2013;19:812–21.
- Lechner J, O’Leary OE, Stitt AW. The pathology associated with diabetic retinopathy. Vis Res. 2017;139:7–14. https://doi.org/10.1016/j.visres.2017.04.003. · DOI · Paper page
- Fu D, Yu JY, Yang S, et al. Survival or death: a dual role for autophagy in stress-induced pericyte loss in diabetic retinopathy. Diabetologia. 2016;59(10):2251–61. https://doi.org/10.1007/s00125-016-4058-5. · DOI
Cited by
Huang, K.-C., Gomes, C., Shiga, Y., Belforte, N., VanderWall, K. B., Lavekar, S. S., Fligor, C. M., Harkin, J., Hetzer, S. M., Patil, S. V., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01872-2 · Cited by 19
Metadata
- Authors
- Madrakhimov, S. B., Yang, J. Y., Kim, J. H., Han, J. W., & Park, T. K.
- Venue
- Cell Communication and Signaling
- Published
- 2021-02-26
- Volume
- 19
- Issue
- 1
- ISSN
- 1478-811X
- Cited by
- 44
- References
- 12
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2019R1A2C1005055)
- Soonchunhyang University
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy. https://app.cochat.ai/papers/10.1186/s12964-020-00698-4
- The paper
- Madrakhimov, S. B., Yang, J. Y., Kim, J. H., Han, J. W., & Park, T. K. (2021). mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy. Cell Communication and Signaling. https://doi.org/10.1186/s12964-020-00698-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.